8-K current report · filed Nov 4, 2026

Steris (STE) 8-K Current Report: November 4, 2026

Item 1.01Item 1.02Item 2.03STE overview

Short answer

Steris (STE) filed an 8-K current report with the SEC on November 4, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 1.02 (Termination of a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation). New $1.6B revolving facility replaces existing agreement, with maturity extended to November 4, 2031.

Steris 8-K event analysis

AI summary of each reported item and its exhibits

Item 1.01 · Entry into a Material Definitive Agreement

  • New $1.6B revolving facility replaces existing agreement, with maturity extended to November 4, 2031
  • Revolver supports liquidity, letters of credit and swingline borrowings, with potential $800M commitment expansion
  • Up to $500M delayed-draw term loan specifically tied to the Xodus Medical acquisition
  • Term loan matures five years after acquisition closing, with no principal amortization during year one
  • Financing adds acquisition capacity while remaining subject to leverage and minimum interest-coverage covenants

Item 1.02 · Termination of a Material Definitive Agreement

  • Existing Revolving Credit Agreement termination disclosed through Item 1.01 cross-reference
  • Investors should review Item 1.01 for replacement financing terms and potential liquidity implications

Item 2.03 · Creation of a Direct Financial Obligation

  • Item 2.03 links to Item 1.01, indicating a material agreement created a direct financial obligation
  • Investors should review Item 1.01 for the obligation’s amount, terms, maturity and business purpose

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Steris 8-K filings

Get the next STE 8-K as it lands

Follow STE for push alerts, or ask the research agent what this filing means.